AstraZeneca PLC ($AZN)
AstraZeneca PLC 
AZN is a pivotal player in the pharmaceutical industry, recognized globally for its comprehensive range of therapies and a deep commitment to innovation in drug development. As a life sciences champion, the company operates with the mission to deliver life-changing medicines to millions of people worldwide.
Real-Time Price Chart for AstraZeneca PLC.
Daily timeframe price chart. Click on chart for more information.
Historical Overview
The narrative of AstraZeneca weaves a tale of strategic growth and scientific progress:
- The company was formed in 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK, each bringing a rich history of pharmaceutical innovation.
- Over the decades, AstraZeneca has made significant strides in developing treatments for various diseases, with a particular focus on cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory illnesses.
- Strategic collaborations and acquisitions, such as the purchase of Cambridge Antibody Technology in 2006 and MedImmune in 2007, have bolstered its biologics division.
- A landmark moment was its pivotal role in developing one of the primary vaccines for COVID-19, partnering with the University of Oxford.
Today, Pascal Soriot serves as CEO of AstraZeneca, which is headquartered in Cambridge, UK, reflecting its commitment to being at the heart of one of the world’s most prominent life sciences clusters. It maintains a vast network of operations and partnerships across the globe.
AstraZeneca PLC’s Seasonality Profile
Seasonality measures the change in price over time on average. Here is how AstraZeneca PLC performs over time. Each bar represents a calendar month. The percentages represent how frequently each calendar month closes higher than the one before it. The vertical line indicates the current month.
Core Business & Operations
AstraZeneca’s business revolves around the discovery, development, manufacturing, and commercialization of prescription medicines, which are primarily categorized into three therapy areas:
- Oncology: A major focus for the company, delivering breakthrough therapies in cancer treatment.
- Cardiovascular, Renal, and Metabolism (CVRM): Addressing diseases with significant unmet medical needs within these specialties.
- Respiratory & Immunology: Offering a suite of medications for chronic respiratory and autoimmune diseases.
Additionally, AstraZeneca is engaged in the research and development of next-generation treatments, including those involving gene editing and personalized healthcare.
Market Presence
In the competitive landscape of big pharma, AstraZeneca stands alongside giants such as:
- Pfizer Inc.: A company known for a wide range of medicines and vaccines, including its own COVID-19 vaccine.
- Novartis AG: A firm with a strong portfolio in various therapeutic areas and a direct competitor in several key markets.
- Merck & Co., Inc.: Another leading pharmaceutical company that competes in the oncology and vaccines space, among others.
Despite this competition, AstraZeneca’s innovative drug pipeline and its strategic collaborations have helped it maintain a prominent place in the industry.
Financial Snapshot
AstraZeneca has demonstrated a pattern of steady growth, with financial reports highlighting strong sales across its key therapeutic areas. Its investment in research and development is reflected in the sustained launch of new products and a rich pipeline of potential therapies, underscoring its commitment to long-term growth and patient care.
AstraZeneca PLC’s Recent Trading Volume
Volume indicates how many shares change hand in a trading session. This chart shows AstraZeneca PLC’s recent market volume for the last 30 trading days on a rolling basis. Elevated volume indicate that there is increased interest in the stock and there is often a reason for this, such as an earnings report, product release, news article, corporate event, or something else.
- View AZN Real Time Price and Volume Chart
- View AZN Options Flow
- View AstraZeneca News
- View AstraZeneca Corporate Profile
Future Outlook
The future of AstraZeneca is intrinsically linked to its robust pipeline and its strategy to remain at the forefront of scientific discovery. With an aging global population and an increasing burden of chronic diseases, the company is positioned to address these challenges head-on. Its ongoing investments in cutting-edge research and its ability to form strategic alliances are expected to drive future success and contributions to global healthcare.
Learn More
To expand your knowledge on AstraZeneca PLC, consider the following resources:
- The AstraZeneca official website for comprehensive information on their healthcare solutions: https://www.astrazeneca.com
- An extensive overview of the company on Wikipedia: https://en.wikipedia.org/wiki/AstraZeneca
- Crunchbase, for insights into the company’s business strategy and performance: https://www.crunchbase.com/organization/astrazeneca
- A snapshot of AstraZeneca’s market performance and financials on Bloomberg: https://www.bloomberg.com/quote/AZN:US
These resources serve as a comprehensive starting point for anyone looking to delve into AstraZeneca’s role in advancing medical science and healthcare.
